News Archives - Page 112 of 1183 - BioHealth Innovation

News

December 12, 2022

Updated: Gilead, Arcellx team up on anti-BCMA CAR-T as biotech touts a 100% response rate at #ASH22 – Endpoints News

Gilead and Kite are plunking down big cash to get into the anti-BCMA CAR-T game. The pair will shell out…

admin

Love0

News

December 12, 2022

Arcellx and Kite Announce Strategic Collaboration to Co-Develop and Co-Commercialize Late-Stage Clinical CART-ddBCMA in Multiple Myeloma

REDWOOD CITY, Calif., and SANTA MONICA, Calif., Dec. 9, 2022 /PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX) and Kite, a Gilead…

admin

Love0

News

December 9, 2022

Maryland Inno – Baltimore biotech Haystack Oncology raises $56M, plans move to City Garage

The Johns Hopkins University researchers behind two of Baltimore's most successful biotech firms have founded a new company that has…

admin

Love0

News

December 8, 2022

New UMD biotech campus to open in Montgomery County in 2023

The University of Maryland is partnering with Montgomery County to develop a new biotech campus near the North Bethesda Metro…

admin

Love0

News

December 8, 2022

Emmes Launches Cell and Gene Therapy Center

Decades of Experience and Emerging Opportunities Led to its Creation ROCKVILLE, Md., Dec. 8, 2022 /PRNewswire/ -- Emmes, a global,…

admin

Love0

News

December 8, 2022

United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2023

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., December 08, 2022--(BUSINESS WIRE)--United Therapeutics (Nasdaq: UTHR), a public benefit corporation, today…

admin

Love0

News

December 6, 2022

Emergent BioSolutions Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for Over-the-Counter NARCAN® (naloxone HCl) Nasal Spray

Emergent’s supplemental new drug application is the first prescription-to-over-the-counter switch application in history to be granted Priority Review by the…

admin

Love0

News

December 5, 2022

DC Inno – Tech transfer program’s mission: Nurture tech-related businesses and retain “highly trained workforce”

University of Maryland College Park (UMCP) graduates are some of the most sought-after graduates in the country – Maryland is…

admin

Love0

News

December 5, 2022

Washingon D.C.’s Vanda Pharmaceuticals Reports Results in a Phase II Clinical Study in the Treatment of Acute Performance Anxiety

WASHINGTON, Dec. 2, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today reported results in a Phase II clinical study of VQW-765,…

admin

Love0

News

December 5, 2022

Life depends on this Molecular “Engine” – LinkedIn

3D Model of ATP Synthase - molecular motor (enzyme) that powers cells, generating chemical energy in the form of ATP…

admin

Love0

News

Updated: Gilead, Arcellx team up on anti-BCMA CAR-T as biotech touts a 100% response rate at #ASH22 – Endpoints News

Arcellx and Kite Announce Strategic Collaboration to Co-Develop and Co-Commercialize Late-Stage Clinical CART-ddBCMA in Multiple Myeloma

Maryland Inno – Baltimore biotech Haystack Oncology raises $56M, plans move to City Garage

New UMD biotech campus to open in Montgomery County in 2023

Emmes Launches Cell and Gene Therapy Center

United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2023

Emergent BioSolutions Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for Over-the-Counter NARCAN® (naloxone HCl) Nasal Spray

DC Inno – Tech transfer program’s mission: Nurture tech-related businesses and retain “highly trained workforce”

Washingon D.C.’s Vanda Pharmaceuticals Reports Results in a Phase II Clinical Study in the Treatment of Acute Performance Anxiety

Life depends on this Molecular “Engine” – LinkedIn

About BioHealth Innovation

Contact

Connect

News

About BioHealth Innovation

Contact

Connect

Search